- Novo Nordisk to Acquire Akero Therapeutics for Up to $5.2 Billion The Wall Street Journal
- Novo Nordisk to buy Akero for up to $5.2 billion in new CEO’s revival push CNBC
- Novo CEO Says Risk-Taking, Deals Are Needed to Win Obesity Race Bloomberg.com
- Novo Nordisk Is Buying Akero Therapeutics. It’s More Good News for Biotech Stocks. Barron’s
- Novo buying Akero and its MASH hopeful for $4.7B upfront FirstWord Pharma
Source link
